- Follow us / Contact us
Newsletter
Subscribe to our scientific newsletter
- Articles suggestions
- Born Too Soon: WHO says simple measures would save most premature babies
- L’économie sociale et solidaire : hier aujourd’hui et demain…
- Social Networks for Scientists
- Open Access + Social Media = Competitive Advantage
- Philippe Kourilsky : « FACTS permet de capitaliser l’expérience acquise sur le terrain par les aides humanitaires »
-
Most popular
- L'information scientifique et technique en libre accès : recherche et veille
- Qu’est ce que la cuisine moléculaire ?
- 9/11 -The collapse of the WTC Twin Towers: the scientific conclusions
- L’évolution de la pratique des réseaux sociaux en science
- Michel Fournier, le grand saut pour bientôt?
- Et si les familles Curie et Joliot-Curie nous parlaient du nucléaire?
- Les Nouveaux Outils Numériques pour la recherche scientifique
- Le projet
- In partnership with
- Our last links
- Born Too Soon: WHO says simple measures would save most premature babies
- L’économie sociale et solidaire : hier aujourd’hui et demain…
- Social Networks for Scientists
- Open Access + Social Media = Competitive Advantage
- Philippe Kourilsky : « FACTS permet de capitaliser l’expérience acquise sur le terrain par les aides humanitaires »
- Les indicateurs de l’évaluation de la recherche : de l’impact factor à l’h-index
- The new digital tools for scientific research
- Les physiciens du CERN détectent une nouvelle particule ‘beauté’
- Join us on Facebook
- our last tweets
Find all the posts for that scientific level
3D Molecular Models, Humanitarian Role Models
Adding to the effects of poverty and limited access to medical care, civil unrest and movement of large populations exacerbate public health problems in the developing world. The parasitic disease leishmaniasis has decimated refugee populations in Africa more than once. Although neglected, for the most part, by drug developers, researchers are seeking more effective treatments, using computer simulations to reveal the structure of individual proteins that they hope to make the parasite’s Achilles heel.
World Cancer Day: Toward a Better Understanding of Breast Cancer Risk
February 4th, marks World Cancer Day, a time to increase awareness and unity in the fight against this disease, responsible for 13% of all deaths worldwide in 2008. Breast cancer, in particular, kills more women than any other type, but research into diverse aspects of the disease continues to progress. Here, we take the opportunity to look at recent advances in understanding breast cancer risk and, from there, to controlling this disease.
A portrait of the astronomer-engineer and humanist, Pierre Fedou
After reading a brief article in Science et vie (Science and life) on his idea of ‘Pulp Vision’, an amusing scroll through his personal yet professional site, and a reading of his blog where one can admire both photos of motorbikes and images of the visual display panel installed on a telescope we decided to meet the author to find out more about his scientific projects. As we ask to meet with him, he apologises for his late reply: “I’m at the top of a mountain for an observation!” We meet with Pierre Fedou, astronaut-engineer and humanist.
What if the Curie and Joliot-Curie families spoke to us of nuclear power?
‘Nothing in life should be feared, everything should be understood’ Marie Curie told her daughters. This phrase expresses all the passion that fuelled this exceptional scientist and female research pioneer. Today, at the heart of the polemic surrounding nuclear power, and at a time when the tsunami-damaged reactors in Fukushima contaminate all North-Eastern Japan, we can ask ourselves if the Curie and Joliot Curie couples suspected the consequences of their discoveries.
The “big revolution”: nanotechnology to nanomedicine
First of an entire folder dedicated to nanotechnology, this article talks about the key role of Richard Feynman in the early story of the application of nanotechnology in medicine and the importance of being small to treat diseases. The purpose of this article is also to show that nanosized drug delivery systems have already entered routine clinical use and that Europe has been pioneering in this field.










